1950s–1960s: Retinoic Acid Identified
-
Scientists isolated all-trans-retinoic acid and 13-cis-retinoic acid as metabolically active derivatives of vitamin A.
-
Animal studies began showing that hypervitaminosis A during pregnancy could lead to fetal malformations.
Experimental Teratology and Pediatric Impact: His groundbreaking experiments, particularly with vitamin deficiencies (like vitamin A and riboflavin) in pregnant rats, definitively showed that environmental factors could cause congenital malformations
1967: Edward Warkany’s Landmark Work
- Dr.
Edward Warkany, a pioneer in teratology, formally described vitamin
A as a teratogen in mammals.
- He
demonstrated that excess vitamin A administered to pregnant rodents
caused craniofacial, cardiac, and neural tube defects.
Warkany is often credited with being the first to link excess vitamin A with congenital malformations in scientific literature.
1980s: Isotretinoin (Accutane) and Human Teratogenicity
- 1982:
Isotretinoin (13-cis-retinoic acid) was approved for severe cystic
acne under the brand name Accutane.
- Soon
after, reports emerged of severe birth defects in infants born to
women who took isotretinoin during pregnancy.
Clinical features described:
- Microtia/anotia
- Conotruncal
heart defects
- Thymic
hypoplasia
- CNS
abnormalities
This became known as Isotretinoin Embryopathy.



.jpg)
.jpeg)

.jpeg)
.jpeg)
.jpeg)




No comments:
Post a Comment